Table I.
Association between the clinicopathological characteristics of the patients with cervical cancer and the serum BK and SCCA expression levels.
| Characteristic | No. of patients | BK (ng/ml) | P-value | SCCA (ng/ml) | P-value |
|---|---|---|---|---|---|
| Age (years) | |||||
| ≥50 | 76 | 8.41±0.64 | 0.3469 | 2.24±0.31 | 0.0975 |
| <50 | 54 | 7.52±0.65 | 1.56±0.27 | ||
| FIGO stage | |||||
| IA - IB | 83 | 8.15±0.61 | 0.7567 | 1.68±0.23 | 0.1281 |
| IIA - IIIB | 47 | 7.85±0.69 | 2.41±0.42 | ||
| Lymph node involvement | |||||
| Yes | 13 | 9.73±1.99 | 0.2845 | 3.28±0.69 | 0.0185 |
| No | 102 | 7.45±0.46 | 1.31±0.13 | ||
| Missed | 15 | ||||
| Differentiation | |||||
| Well-moderately differentiated | 63 | 7.77±0.57 | 0.9889 | 1.94±0.28 | 0.8746 |
| Poorly differentiated | 39 | 7.78±0.94 | 2.00±0.33 | ||
| Missed | 28 | ||||
| Pathological type | |||||
| Squamous carcinoma | 102 | 7.76±0.48 | 0.2475 | 2.17±0.26 | 0.0025 |
| Adenocarcinoma | 28 | 9.06±1.21 | 1.08±0.24 |
FIGO, International Federation of Gynecology and Obstetrics; BK, bradykinin; SCCA, squamous cell carcinoma-related antigen.